| Name | nuclear receptor binding SET domain protein 3 |
| Description | This gene is related to the Wolf-Hirschhorn syndrome candidate-1 gene and encodes a protein with PWWP (proline-tryptophan-tryptophan-proline) domains. This protein methylates histone H3 at lysine residues 4 and 27, which represses gene transcription. Two alternatively spliced variants have been described. [provided by RefSeq, May 2015] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNSD3 is a multifunctional regulator of chromatin structure and transcription. By methylating histone H3 at lysine 36 and engaging in direct protein–protein interactions, NSD3 modulates the local chromatin microenvironment at target genes. Structural and biochemical studies have revealed that NSD3’s catalytic activity, as well as its non‐catalytic isoforms, is tightly regulated by its binding to nucleosomes and by formation of multi‐protein complexes—including partnerships with BET proteins such as BRD4—which together control transcriptional activation through H3K36 methylation and chromatin remodeling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDysregulation of NSD3—whether by gene amplification, oncogenic fusion events, activating mutations, or aberrant overexpression—has been implicated in the pathogenesis of a wide range of human cancers. In some tumors, such as NUT midline carcinoma, an NSD3 fusion oncoprotein is sufficient to block differentiation and maintain proliferation. In lung squamous cell carcinoma, breast cancer (including luminal B subtypes), osteosarcoma, pancreatic, and head and neck cancers, NSD3 alterations correlate with abnormal H3K36 methylation, deregulation of cell cycle–linked and oncogenic transcriptional programs, and enhanced tumor growth. In several contexts, even subtle changes in NSD3 activity reprogram the epigenome—for example by engaging NOTCH signaling or affecting metabolic gene expression—thereby driving malignant transformation and progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistically, isoform-specific functions of NSD3 further diversify its role in cancer biology. The short, noncatalytic isoform functions as an adaptor protein that can stabilize oncogenic factors such as MYC by interfering with their proteasomal degradation, while the long, catalytic isoform directly modulates transcription by depositing H3K36 methylation marks and regulating cell cycle progression. Additionally, NSD3 activity has been linked to alterations in cellular energy metabolism, underscoring its emerging role in metabolic reprogramming in cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Shaila Rahman, Mathew E Sowa, Matthias Ottinger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01341-10"}], "href": "https://doi.org/10.1128/MCB.01341-10"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21555454"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21555454"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Chen Shen, Jonathan J Ipsaro, Junwei Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2015.10.033"}], "href": "https://doi.org/10.1016/j.molcel.2015.10.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26626481"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26626481"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Wanqiu Li, Wei Tian, Gang Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-020-03069-8"}], "href": "https://doi.org/10.1038/s41586-020-03069-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33361816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33361816"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Sriram Aiyer, G V T Swapna, Li-Chung Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A common binding motif in the ET domain of BRD3 forms polymorphic structural interfaces with host and viral proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Structure (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.str.2021.01.010"}], "href": "https://doi.org/10.1016/j.str.2021.01.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33592170"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33592170"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Mengmeng Zhang, Yinxue Yang, Mengqi Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histone and DNA binding ability studies of the NSD subfamily of PWWP domains."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2021.07.017"}], "href": "https://doi.org/10.1016/j.bbrc.2021.07.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34271259"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34271259"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Zhangle Zhou, Rune Thomsen, Søren Kahns, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The NSD3L histone methyltransferase regulates cell cycle and cell invasion in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.06.119"}], "href": "https://doi.org/10.1016/j.bbrc.2010.06.119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20599755"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20599755"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Zeng-Quan Yang, Gang Liu, Aliccia Bollig-Fischer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming properties of 8p11-12 amplified genes in human breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-1013"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-1013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20940404"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20940404"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Daechun Kang, Hyun-Soo Cho, Gouji Toyokawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.22012"}], "href": "https://doi.org/10.1002/gcc.22012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23011637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23011637"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Chao He, Fudong Li, Jiahai Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The methyltransferase NSD3 has chromatin-binding motifs, PHD5-C5HCH, that are distinct from other NSD (nuclear receptor SET domain) family members in their histone H3 recognition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.426148"}], "href": "https://doi.org/10.1074/jbc.M112.426148"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23269674"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23269674"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Sardar F Mahmood, Nadège Gruel, Rémy Nicolle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajpath.2013.07.028"}], "href": "https://doi.org/10.1016/j.ajpath.2013.07.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24051013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24051013"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Christopher A French, Shaila Rahman, Erica M Walsh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Discov (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2159-8290.CD-14-0014"}], "href": "https://doi.org/10.1158/2159-8290.CD-14-0014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24875858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24875858"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Masayo Morishita, Damiaan Mevius, Eric di Luccio "}, {"type": "b", "children": [{"type": "t", "text": "In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Struct Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12900-014-0025-x"}], "href": "https://doi.org/10.1186/s12900-014-0025-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25494638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25494638"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Theodore Vougiouklakis, Ryuji Hamamoto, Yusuke Nakamura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The NSD family of protein methyltransferases in human cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenomics (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/epi.15.32"}], "href": "https://doi.org/10.2217/epi.15.32"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25942451"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25942451"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jonathan C Irish, Jamie N Mills, Brittany Turner-Ivey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molonc.2016.02.003"}], "href": "https://doi.org/10.1016/j.molonc.2016.02.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27005559"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27005559"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Vassiliki Saloura, Theodore Vougiouklakis, Makda Zewde, et al. "}, {"type": "b", "children": [{"type": "t", "text": "WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9897"}], "href": "https://doi.org/10.18632/oncotarget.9897"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27285764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27285764"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Brittany Turner-Ivey, Ericka L Smith, Alex C Rutkovsky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-017-4258-9"}], "href": "https://doi.org/10.1007/s10549-017-4258-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28484924"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28484924"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Zhiwei Liu, Lianhua Piao, Ming Zhuang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2017.5936"}], "href": "https://doi.org/10.3892/or.2017.5936"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28901481"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28901481"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Ga-Young Jeong, Mi Kyung Park, Hee-Joo Choi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-20-0360"}], "href": "https://doi.org/10.1158/0008-5472.CAN-20-0360"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32967925"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32967925"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Gang Yuan, Natasha M Flores, Simone Hausmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated NSD3 histone methylation activity drives squamous cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-020-03170-y"}], "href": "https://doi.org/10.1038/s41586-020-03170-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33536620"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33536620"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yihui Sun, Jiaming Xie, Shang Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-04205-6"}], "href": "https://doi.org/10.1038/s41419-021-04205-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34615858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34615858"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Iuliia Topchu, Rajendra P Pangeni, Igor Bychkov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Life Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00018-022-04321-2"}], "href": "https://doi.org/10.1007/s00018-022-04321-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35532818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35532818"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Yanling Zhou, Xintong Peng, Cheng Fang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histones Methyltransferase NSD3 Inhibits Lung Adenocarcinoma Glycolysis Through Interacting with PPP1CB to Decrease STAT3 Signaling Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Adv Sci (Weinh) (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/advs.202400381"}], "href": "https://doi.org/10.1002/advs.202400381"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39119928"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39119928"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Germana B Rona, Natalia P Almeida, Gilson C Santos, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "1"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " H NMR metabolomics reveals increased glutaminolysis upon overexpression of NSD3s or Pdp3 in Saccharomyces cerevisiae."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.27816"}], "href": "https://doi.org/10.1002/jcb.27816"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30320908"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30320908"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Valentina Gonzalez-Pecchi, Albert K Kwan, Sean Doyle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NSD3S stabilizes MYC through hindering its interaction with FBXW7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Cell Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jmcb/mjz098"}], "href": "https://doi.org/10.1093/jmcb/mjz098"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31638140"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31638140"}]}]}]}
|
| NCBI Gene ID | 54904 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NSD3 has 3,186 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 43 datasets.
Click the + buttons to view associations for NSD3 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NSD3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NSD3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with NSD3 protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NSD3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of NSD3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NSD3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NSD3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving NSD3 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NSD3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NSD3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NSD3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NSD3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NSD3 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NSD3 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing NSD3 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing NSD3 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NSD3 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NSD3 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NSD3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NSD3 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NSD3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by NSD3 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NSD3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NSD3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| KEGG Pathways 2026 | pathways involving NSD3 protein from the KEGG Pathways 2026 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of NSD3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NSD3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NSD3 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for NSD3 protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NSD3 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NSD3 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NSD3 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving NSD3 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NSD3 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NSD3 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of NSD3 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NSD3 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NSD3 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of NSD3 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of NSD3 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NSD3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NSD3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NSD3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |